GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.
GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training. The network includes over 150 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.
GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.
0
Network Investigators
0
Trained HQP
0
Funded Projects
0
Network Partners
Latest News
New GlycoNet Trainee Association Executive Committee announced
GlycoNet trainees will receive support to advance their professional development and promote their research activities.
The light at the end of the tunnel for heart failure
GlycoNet Investigators identified carbohydrate-derived molecules that may hold the key to preventing and treating the disease for which there is currently no cure.
Sweet science: Sugar research gets $20M stronger
GlycoNet’s Associate Director Clinical Partnerships, Dr. Lara Mahal, is bringing personalized health care to reality.
GlycoNet/ACS Joint Webinar Series
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 78-492-6204
Fax: 780-492-4147
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.
English 
French